Theranostics 2020; 10(16):7403-7405. doi:10.7150/thno.48966


Critical reviews of immunotheranostics

Xiaoyuan Chen1✉, Mingnan Chen2 ✉

1. Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Maryland 20892, USA
2. Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112, USA

This is an open access article distributed under the terms of the Creative Commons Attribution License ( See for full terms and conditions.
Chen X, Chen M. Critical reviews of immunotheranostics. Theranostics 2020; 10(16):7403-7405. doi:10.7150/thno.48966. Available from

File import instruction


Immunity is the most critical and well-regulated protection to the body. Immunity is implicated in a wide range of diseases and serves as the foundation for immunotherapy. Immunotheranostics is the idea of improving immunotherapy through the organic integration of therapeutic, diagnostic, and screening technologies. This special issue collects reviews and opinions from prominent contributors in the immunotheranostic field who represent highly diversified research expertise. The immunotherapeutics discussed in this issue range from small molecules, peptides, antibodies, nanoparticles, and to cells. Discussions from the therapeutic development perspective are accompanied by opinions from the biology and medicine aspects. Further, there are reviews about different types of imaging technologies and their applications in immunotherapy. Lastly, one review raises attention to mass spectrometry for its utilization in the diagnosis and assessment for immunotherapy. In summary, this special issue is a showcase for what is happening in immunotheranostics. Moreover, it is also a justified wish list for what should and will happen in immunotheranostics.

Keywords: Immunotherapy, theranostics, drug, imaging, screening